Technical Analysis for ANIP - ANI Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
B 38.6 10.29% 3.60
ANIP closed up 10.29 percent on Friday, May 7, 2021, on 2.1 times normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical ANIP trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Reversal New Highs Setup Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week High Strength 0.00%
Earnings Movers Other 0.00%
BB Squeeze Ended Range Expansion 0.00%
Outside Day Range Expansion 0.00%
Above Upper BB Strength 0.00%
Older End-of-Day Signals for ANIP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ANI Pharmaceuticals, Inc. Description

ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. It offers liquid, powder, oral solid dose, and cough/cold products; and antacids, laxatives, and other stomach remedies. The company also provides hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture, and metoclopramide tablets. In addition, ANI Pharmaceuticals offers contract manufacturing services for other pharmaceutical companies. It offers its products through wholesalers, smaller regional distributors and chains, and pharmacy and retail outlets in the United States. ANI Pharmaceuticals, Inc. was formerly known as ASHCO. The company was founded in 2001 and is based in Baudette, Minnesota. It has manufacturing facilities in Gulfport, Mississippi; and Baudette, Minnesota. ANI Pharmaceuticals, Inc. is a former subsidiary of Bactolac Pharmaceutical Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Acid Retail Outlets Pharmacology Acids Suspension Contract Manufacturing Chloroarenes Manufacturing Facilities Contract Manufacturing Services Cough Estrogen Testosterone Antiemetics Antacid Laxatives Enema Metoclopramide Offers Contract Manufacturing Services Prolactin Releasers

Is ANIP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 39.9999
52 Week Low 23.55
Average Volume 58,691
200-Day Moving Average 30.42
50-Day Moving Average 32.74
20-Day Moving Average 33.93
10-Day Moving Average 34.23
Average True Range 1.77
ADX 15.34
+DI 33.62
-DI 11.70
Chandelier Exit (Long, 3 ATRs ) 34.68
Chandelier Exit (Short, 3 ATRs ) 36.67
Upper Bollinger Band 36.58
Lower Bollinger Band 31.27
Percent B (%b) 1.38
BandWidth 15.67
MACD Line 0.82
MACD Signal Line 0.45
MACD Histogram 0.3644
Fundamentals Value
Market Cap 476.62 Million
Num Shares 12.3 Million
EPS 1.34
Price-to-Earnings (P/E) Ratio 28.87
Price-to-Sales 1.76
Price-to-Book 1.85
PEG Ratio 1.06
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 47.52
Resistance 3 (R3) 47.00 43.50 46.04
Resistance 2 (R2) 43.50 41.23 43.76 45.54
Resistance 1 (R1) 41.05 39.82 42.27 41.57 45.05
Pivot Point 37.55 37.55 38.16 37.81 37.55
Support 1 (S1) 35.10 35.28 36.33 35.63 32.15
Support 2 (S2) 31.60 33.87 31.86 31.66
Support 3 (S3) 29.15 31.60 31.16
Support 4 (S4) 29.68